Vitex Joining Red Blood Cell Viral Inactivation System Development Race
This article was originally published in The Gray Sheet
Executive Summary
An invesitigation device exemption submission for Vitex' RBCC red blood cell viral inactivation system is expected in the second half of 1999, the Melville, New York-based company reports.